Thrivent Financial for Lutherans
ELV icon

Thrivent Financial for Lutherans’s Elevance Health ELV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$6.87M Sell
17,693
-3,422
-16% -$1.33M 0.02% 699
2025
Q1
$9.17M Sell
21,115
-279,169
-93% -$121M 0.02% 640
2024
Q4
$111M Sell
300,284
-6,545
-2% -$2.42M 0.21% 100
2024
Q3
$160M Sell
306,829
-6,912
-2% -$3.59M 0.3% 63
2024
Q2
$170M Sell
313,741
-4,173
-1% -$2.26M 0.34% 47
2024
Q1
$165M Buy
317,914
+64,728
+26% +$33.6M 0.33% 59
2023
Q4
$119M Sell
253,186
-10,304
-4% -$4.86M 0.26% 93
2023
Q3
$115M Buy
263,490
+192
+0.1% +$83.6K 0.27% 89
2023
Q2
$117M Sell
263,298
-193,150
-42% -$85.8M 0.27% 90
2023
Q1
$210M Sell
456,448
-35,690
-7% -$16.4M 0.51% 22
2022
Q4
$252M Buy
492,138
+21,014
+4% +$10.8M 0.65% 13
2022
Q3
$214M Buy
471,124
+63,067
+15% +$28.6M 0.59% 17
2022
Q2
$197M Sell
408,057
-75,535
-16% -$36.5M 0.52% 21
2022
Q1
$238M Buy
483,592
+33,907
+8% +$16.7M 0.46% 29
2021
Q4
$208M Buy
449,685
+2,465
+0.6% +$1.14M 0.4% 46
2021
Q3
$167M Buy
447,220
+171,891
+62% +$64.1M 0.34% 59
2021
Q2
$105M Buy
275,329
+5,547
+2% +$2.12M 0.21% 118
2021
Q1
$96.8M Buy
269,782
+57,980
+27% +$20.8M 0.21% 111
2020
Q4
$68M Buy
211,802
+26,396
+14% +$8.48M 0.16% 160
2020
Q3
$49.8M Buy
185,406
+85,013
+85% +$22.8M 0.13% 187
2020
Q2
$26.3M Buy
100,393
+84,038
+514% +$22M 0.08% 289
2020
Q1
$3.71M Sell
16,355
-42,702
-72% -$9.69M 0.01% 732
2019
Q4
$17.8M Buy
59,057
+27,691
+88% +$8.36M 0.05% 411
2019
Q3
$7.53M Buy
31,366
+1,065
+4% +$256K 0.02% 574
2019
Q2
$8.55M Buy
30,301
+1,770
+6% +$500K 0.03% 564
2019
Q1
$8.19M Sell
28,531
-10,684
-27% -$3.07M 0.03% 545
2018
Q4
$10.3M Sell
39,215
-5,966
-13% -$1.57M 0.04% 441
2018
Q3
$12.4M Sell
45,181
-2,808
-6% -$770K 0.04% 439
2018
Q2
$11.4M Sell
47,989
-29,891
-38% -$7.12M 0.04% 461
2018
Q1
$17.1M Buy
77,880
+49,225
+172% +$10.8M 0.06% 328
2017
Q4
$6.45M Sell
28,655
-92
-0.3% -$20.7K 0.02% 573
2017
Q3
$5.46M Sell
28,747
-825
-3% -$157K 0.02% 584
2017
Q2
$5.56M Buy
29,572
+3,920
+15% +$738K 0.02% 540
2017
Q1
$4.24M Buy
25,652
+8,880
+53% +$1.47M 0.02% 622
2016
Q4
$2.41M Buy
16,772
+4,702
+39% +$676K 0.01% 800
2016
Q3
$1.51M Buy
12,070
+4,000
+50% +$501K 0.01% 966
2016
Q2
$1.06M Buy
8,070
+380
+5% +$49.9K 0.01% 1073
2016
Q1
$1.07M Buy
7,690
+450
+6% +$62.6K 0.01% 1053
2015
Q4
$1.01M Buy
7,240
+40
+0.6% +$5.58K ﹤0.01% 1064
2015
Q3
$1.01M Buy
7,200
+300
+4% +$42K 0.01% 959
2015
Q2
$1.13M Buy
6,900
+300
+5% +$49.3K 0.01% 789
2015
Q1
$1.02M Sell
6,600
-93,350
-93% -$14.4M 0.01% 838
2014
Q4
$12.6M Sell
99,950
-6,200
-6% -$779K 0.07% 282
2014
Q3
$12.7M Buy
106,150
+36,800
+53% +$4.4M 0.07% 264
2014
Q2
$7.46M Buy
69,350
+32,900
+90% +$3.54M 0.04% 385
2014
Q1
$3.63M Sell
36,450
-14,350
-28% -$1.43M 0.02% 488
2013
Q4
$4.69M Buy
50,800
+2,400
+5% +$222K 0.03% 452
2013
Q3
$4.05M Buy
48,400
+38,000
+365% +$3.18M 0.03% 470
2013
Q2
$851 Buy
+10,400
New +$851 0.01% 740